Page last updated: 2024-09-04

varespladib and Arthritis, Rheumatoid

varespladib has been researched along with Arthritis, Rheumatoid in 2 studies

*Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arjunan, P; Gopalakrishnakone, P; Kumar, PV; Nagarajarao, LM; Ramapatna, SL; Sato, K; Satyanarayanajois, SD; Thwin, MM1
Bradley, JD; Dmitrienko, AA; Gluck, OS; Kivitz, AJ; Myers, SL; Sides, GD; Weaver, AL; Wiesenhutter, C1

Trials

1 trial(s) available for varespladib and Arthritis, Rheumatoid

ArticleYear
A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.
    The Journal of rheumatology, 2005, Volume: 32, Issue:3

    Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Indoles; Keto Acids; Middle Aged; Phospholipases A; Phospholipases A2; Placebos

2005

Other Studies

1 other study(ies) available for varespladib and Arthritis, Rheumatoid

ArticleYear
Novel peptide inhibitors of human secretory phospholipase A2 with antiinflammatory activity: solution structure and molecular modeling.
    Journal of medicinal chemistry, 2007, Nov-29, Volume: 50, Issue:24

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cells, Cultured; Circular Dichroism; Fibroblasts; Gene Expression; Humans; Magnetic Resonance Spectroscopy; Matrix Metalloproteinases; Models, Molecular; Oligopeptides; Peptides; Peptides, Cyclic; Phospholipases A2, Secretory; Protein Binding; Protein Conformation; Rabbits; Solutions; Structure-Activity Relationship; Synovial Fluid

2007